Targeting Specific Immunologic Pathways in Crohn's Disease

Guilherme Piovezani Ramos, William Alvis Faubion, Konstantinos Papadakis

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Understanding the immunologic pathways in intestinal inflammation is crucial for the development of new therapies that can maximize patient response and minimize toxicity. Targeting integrins and cytokines is intended to control leukocyte migration to effector sites or inhibit the action of proinflammatory cytokines. New approaches to preventing leukocyte migration may target integrin receptors expressed on the intestinal vascular endothelium. The IL-12/IL-23 pathway has been a therapeutic target of interest in controlling active Crohn disease (CD). New therapeutic approaches in CD may involve the enhancement of antiinflammatory cytokine pathways, and modulation of cellular responses and intranuclear signals associated with intestinal inflammation.

Original languageEnglish (US)
JournalGastroenterology Clinics of North America
StateAccepted/In press - 2017


  • Crohn's disease
  • Immunology
  • Inflammatory bowel diseases
  • Target therapy

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Targeting Specific Immunologic Pathways in Crohn's Disease'. Together they form a unique fingerprint.

Cite this